Skip to content
Riskpilot
← Back to search
Sign in
Get full access
EntoPrime ApS
APS
Active
Advertising protection
CVR 44434903
Universitetsbyen 76, 8000
Aarhus C
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2023 · 2 years old
3 employees
https://entoprime.com/
Monitor
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
EntoPrime ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
1M
1M
1M
0M
0M
0M
2024
1M
+100%
2025
EBITDA
DKK millions
0M
0M
0M
-1M
-1M
0M
2024
0M
0%
2025
Income statement
DKK thousands
Item
2024
2025
Gross profit
398
543
Staff expenses
-319
-302
EBITDA
79
241
Depreciation & amort.
-0
-0
EBIT
79
241
Net financials
-2
-1
Profit before tax
77
240
Tax
12
47
Net profit
65
194
Balance sheet
DKK thousands
Item
2024
2025
Total assets
1.147
975
Equity
405
521
Long-term debt
0
0
Short-term debt
742
454
Total debt
742
454
Financial ratios
5-year trend
EBITDA margin (of gross profit)
44.4%
This company
2024
2025
Equity ratio
53.4%
This company
38.2%
Market median
40% above market
2024
2025
Return on equity
37.2%
This company
18.4%
Market median
102% above market
2024
2025
Net profit margin (of gross profit)
35.6%
This company
2024
2025
Asset turnover (of gross profit)
0.56×
This company
2024
2025
Debt / equity
0.87×
This company
0.62×
Market median
40% above market
2024
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2023-11-16 – 2024-12-31
View
PDF
More on EntoPrime ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
